Characteristics | Study cohort n = 471 | |||
---|---|---|---|---|
Total | (% missing) | Cases ( n) | (%) | |
General characteristics | Â | Â | Â | Â |
Male gender a | 471 | (0) | 260 | 55.2% |
Outcome measure | Â | Â | Â | Â |
Hearing loss a | 471 | (0) | 34 | 7.2% |
Clinical predictors | Â | Â | Â | Â |
Duration of symptoms > 2 daysa | 464 | (1.5) | 110 | 23.7% |
Petechiae a | 463 | (1.7) | 273 | 59.0% |
CSF glucose ≤ 0.6 mmol/l a | 418 | (11.2) | 125 | 29.9% |
Causative pathogen in CSF: | 471 | (0) | Â | Â |
N. meningitidis a | Â | Â | 391 | 83% |
S. pneumoniae a | Â | Â | 80 | 17% |
(transient) ataxia a. b | 471 | (0) | 16 | 3.4% |